About Marc Cohen
Marc Cohen filed with the SEC as chief executive officer and director of C4 Therapeutics from 2020 to 2022.
Form D filings name Marc Cohen as an executive officer and director at AI Proteins.
Marc Cohen reports to the SEC as a director, officer or major shareholder of 3 public companies, including Korro Bio (KRRO) and Opnet Technologies (OPNT).
Marc Cohen first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Marc Cohen in the role, so the role may have started earlier or lasted longer.
CI
C4 Therapeutics, Inc.
Chief Executive Officer and director
2020 – 2022 · Public company (CCCC)
KI
Korro Bio, Inc.
Director
2019 – 2022 · Public company (KRRO)
OI
Opnet Technologies Inc.
Chairman, CEO, Treas & Secy
2006 – 2012 · Public company (OPNT)
Key Colleagues at Startups
The people Marc Cohen works with at each company, as listed on that company's latest Form D.
AI Proteins, Inc. · Form D, Jan 21, 2022
DV
Dominique Verhelle
Director
BM
Bill McKee
Director
JN
Julia Novina
Chief Legal Officer
GM
Geoff Meyerson
Director
EP
Elena Prokupets
Director
CN
Carl Novina
Director
DD
Drew Dennison
Director
NB
Namandje Bumpus
Director
AB
Arthur Becker
Director
CB
Chris Bahl
Executive officer and director
MS
Malcolm Salter
Director